19th World Dermatology Congress
Title: EFFICACY OF PLATELET RICH FIBRIN CLOT IN TREATMENT OF TROPHIC ULCERS IN HANSEN’S DISEASE
Biography: Anugandha Ghatge
Trophic ulcers secondary to leprosy pose a great stigma to the patients and remain a challenge to the treating dermatologists. The discovery of Platelet Rich Fibrin clot (PRF) with its favourable role in wound healing is a boon for the patients. PRF introduces the growth factors directly into the wound and aids in rapid healing. There has been less study performed for its use in trophic ulcers in hansen’s disease so our study brings out the use PRF in treating non healing ulcers in hansens disease. 5 patients (50%) showed complete healing, in 4 patients (40%) there was marked reduction in wound size and 1 patient (10%) lost to follow up. Mean healing time of ulcer is 5 weeks. PRF therapy leads to faster rate of induction of granulation tissue with rapid healing. It is a simple, safe and cost effective opd procedure, albeit requiring an optimal set-up and expertise. More sample size will be required for definitive results.